Marker Therapeutics, Inc.
(NASDAQ : TPIV)

( )
TPIV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Consumer Services » Other Consumer Services
symbolcompany%chnglast%shortavg$volume
EBAYeBay Inc.
0.65%36.981.7%$565.23m
EXPEExpedia, Inc.
-0.38%128.106.8%$225.63m
EDUNew Oriental Education & Technology Group, Inc. Sponsored ADR
-1.10%78.411.3%$131.57m
CTRPCtrip.com International Ltd Sponsored ADR
-3.79%32.524.3%$120.26m
TRIPTripAdvisor, Inc.
-1.84%54.3813.0%$117.91m
HRBH&R Block, Inc.
2.89%24.5911.2%$89.46m
WTWWeight Watchers International, Inc.
-4.59%29.0814.7%$73.59m
CHGGChegg, Inc.
2.24%38.3216.5%$73.36m
ROLRollins, Inc.
0.69%39.622.7%$65.86m
PLNTPlanet Fitness Inc Class A
-0.39%58.2511.5%$65.85m
LOPEGrand Canyon Education, Inc.
21.40%117.952.0%$45.95m
SERVServiceMaster Global Holdings Inc
0.05%39.084.7%$41.37m
ESIITT Educational Services, Inc.
-0.62%11.2736.9%$38.66m
SCIService Corporation International
-1.08%42.275.2%$38.65m
NTRINutrisystem, Inc.
-0.02%43.463.7%$30.03m

Company Profile

Marker Therapeutics, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL.